▶ 調査レポート

救命救急機器のグローバル市場(~2027):輸液ポンプ、患者モニター、人工呼吸器

• 英文タイトル:Critical Care Equipment Market Research Report by Product Type, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

Critical Care Equipment Market Research Report by Product Type, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19「救命救急機器のグローバル市場(~2027):輸液ポンプ、患者モニター、人工呼吸器」(市場規模、市場予測)調査レポートです。• レポートコード:MRC2305B142
• 出版社/出版日:360iResearch / 2022年10月
• レポート形態:英語、PDF、232ページ
• 納品方法:Eメール(受注後2-3日)
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User(1名利用、印刷可)¥742,350 (USD4,949)▷ お問い合わせ
  Enterprise License(企業利用、印刷可)¥1,492,350 (USD9,949)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
360iResearch社は、2021年に1,655.17百万ドルであった世界の救命救急機器市場規模が、2022年には1,758.06百万ドルに達し、2027年までに年平均6.39%成長して2,400.66百万ドルになると予測しています。当調査資料では、救命救急機器の世界市場について調査・分析を行い、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品タイプ別分析(輸液ポンプ、患者モニター、人工呼吸器)、エンドユーザー別分析(家庭、病院、医療センター)、地域別分析(南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他)、競争状況、企業情報などの項目をまとめました。なお、当書に掲載されている企業情報には、3M Company、Align Technology、Allergan PLC、Amplifon SpA、B. Braun Melsungen AG、Baxter International、Becton, Dickinson & Company、Boston Scientific Corp、BPL Medical Technologies Pvt Ltd、Cardinal Health Inc.、Coloplast A/S、Danaher Corporationなどが含まれています。

・序論
・調査方法
・エグゼクティブサマリー
・市場概要
・市場インサイト
・世界の救命救急機器市場規模:製品タイプ別
- 輸液ポンプの市場規模
- 患者モニターの市場規模
- 人工呼吸器の市場規模
・世界の救命救急機器市場規模:エンドユーザー別
- 家庭における市場規模
- 病院における市場規模
- 医療センターにおける市場規模
・世界の救命救急機器市場規模:地域別
- 南北アメリカの救命救急機器市場規模
アメリカの救命救急機器市場規模
カナダの救命救急機器市場規模
ブラジルの救命救急機器市場規模
...
- アジア太平洋の救命救急機器市場規模
日本の救命救急機器市場規模
中国の救命救急機器市場規模
インドの救命救急機器市場規模
韓国の救命救急機器市場規模
台湾の救命救急機器市場規模
...
- ヨーロッパ/中東/アフリカの救命救急機器市場規模
イギリスの救命救急機器市場規模
ドイツの救命救急機器市場規模
フランスの救命救急機器市場規模
ロシアの救命救急機器市場規模
...
- その他地域の救命救急機器市場規模
・競争状況
・企業情報

The Global Critical Care Equipment Market size was estimated at USD 1,655.17 million in 2021 and expected to reach USD 1,758.06 million in 2022, and is projected to grow at a CAGR 6.39% to reach USD 2,400.66 million by 2027.

Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:
This research report categorizes the Critical Care Equipment to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product Type, the market was studied across Infusion Pumps, Patient Monitors, and Ventilators.

Based on End User, the market was studied across Homes, Hospitals, and Medical Centers.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Critical Care Equipment market considering the current update on the conflict and its global response.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Critical Care Equipment Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Critical Care Equipment Market, including 3M Company, Align Technology, Allergan PLC, Amplifon SpA, B. Braun Melsungen AG, Baxter International, Becton, Dickinson & Company, Boston Scientific Corp, BPL Medical Technologies Pvt Ltd, Cardinal Health Inc., Coloplast A/S, Danaher Corporation, Draegerwerk AG & Co KGaA, Edwards LifeSciences Corp, Fresenius Medical Care AG & Co. KGaA, General Electric Company, Haemonetics Corporation, Hill-Rom Holdings Inc., Hologic Inc., Hoya Corp, Intuitive Surgical Inc., Johnson & Johnson, Koninklijke Philips N.V., MAQUET Holding B.V. & Co. KG., Medtronic plc, Nihon Kohden Corporation, Olympus Corporation, ResMed Inc., Sartorius Stedim Biotech S.A., Siemens Healthineers, Skanray Technologies Pvt. Ltd, Smith & Nephew PLC, Smiths Medical, Inc., Steris PLC, Straumann Holding AG, Stryker Corporation, Teleflex Inc., Terumo Corporation, The Cooper Companies Inc., and Zimmer Biomet Holdings.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Critical Care Equipment Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Critical Care Equipment Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Critical Care Equipment Market?
4. What is the competitive strategic window for opportunities in the Global Critical Care Equipment Market?
5. What are the technology trends and regulatory frameworks in the Global Critical Care Equipment Market?
6. What is the market share of the leading vendors in the Global Critical Care Equipment Market?
7. What modes and strategic moves are considered suitable for entering the Global Critical Care Equipment Market?

レポート目次

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising geriatric population worldwide and increase in prevalence of chronic diseases
5.1.1.2. Adoption of digitization trends and illness due to sedentary lifestyle
5.1.1.3. Large investments in the healthcare sector for modern medical treatments facilities
5.1.2. Restraints
5.1.2.1. High cost of critical care equipment
5.1.3. Opportunities
5.1.3.1. Government activities and support for implementing critical care diagnostics
5.1.3.2. Rapidly incorporated new technologies and advances in devices such as monitors
5.1.4. Challenges
5.1.4.1. Lack of skilled professionals
5.2. Cumulative Impact of COVID-19

6. Critical Care Equipment Market, by Product Type
6.1. Introduction
6.2. Infusion Pumps
6.3. Patient Monitors
6.4. Ventilators

7. Critical Care Equipment Market, by End User
7.1. Introduction
7.2. Homes
7.3. Hospitals
7.4. Medical Centers

8. Americas Critical Care Equipment Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Critical Care Equipment Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Critical Care Equipment Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis, By Key Player
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. 3M Company
12.1.1. Business Overview
12.1.2. Key Executives
12.1.3. Product & Services
12.2. Align Technology
12.2.1. Business Overview
12.2.2. Key Executives
12.2.3. Product & Services
12.3. Allergan PLC
12.3.1. Business Overview
12.3.2. Key Executives
12.3.3. Product & Services
12.4. Amplifon SpA
12.4.1. Business Overview
12.4.2. Key Executives
12.4.3. Product & Services
12.5. B. Braun Melsungen AG
12.5.1. Business Overview
12.5.2. Key Executives
12.5.3. Product & Services
12.6. Baxter International
12.6.1. Business Overview
12.6.2. Key Executives
12.6.3. Product & Services
12.7. Becton, Dickinson & Company
12.7.1. Business Overview
12.7.2. Key Executives
12.7.3. Product & Services
12.8. Boston Scientific Corp
12.8.1. Business Overview
12.8.2. Key Executives
12.8.3. Product & Services
12.9. BPL Medical Technologies Pvt Ltd
12.9.1. Business Overview
12.9.2. Key Executives
12.9.3. Product & Services
12.10. Cardinal Health Inc.
12.10.1. Business Overview
12.10.2. Key Executives
12.10.3. Product & Services
12.11. Coloplast A/S
12.11.1. Business Overview
12.11.2. Key Executives
12.11.3. Product & Services
12.12. Danaher Corporation
12.12.1. Business Overview
12.12.2. Key Executives
12.12.3. Product & Services
12.13. Draegerwerk AG & Co KGaA
12.13.1. Business Overview
12.13.2. Key Executives
12.13.3. Product & Services
12.14. Edwards LifeSciences Corp
12.14.1. Business Overview
12.14.2. Key Executives
12.14.3. Product & Services
12.15. Fresenius Medical Care AG & Co. KGaA
12.15.1. Business Overview
12.15.2. Key Executives
12.15.3. Product & Services
12.16. General Electric Company
12.16.1. Business Overview
12.16.2. Key Executives
12.16.3. Product & Services
12.17. Haemonetics Corporation
12.17.1. Business Overview
12.17.2. Key Executives
12.17.3. Product & Services
12.18. Hill-Rom Holdings Inc.
12.18.1. Business Overview
12.18.2. Key Executives
12.18.3. Product & Services
12.19. Hologic Inc.
12.19.1. Business Overview
12.19.2. Key Executives
12.19.3. Product & Services
12.20. Hoya Corp
12.20.1. Business Overview
12.20.2. Key Executives
12.20.3. Product & Services
12.21. Intuitive Surgical Inc.
12.21.1. Business Overview
12.21.2. Key Executives
12.21.3. Product & Services
12.22. Johnson & Johnson
12.22.1. Business Overview
12.22.2. Key Executives
12.22.3. Product & Services
12.23. Koninklijke Philips N.V.
12.23.1. Business Overview
12.23.2. Key Executives
12.23.3. Product & Services
12.24. MAQUET Holding B.V. & Co. KG.
12.24.1. Business Overview
12.24.2. Key Executives
12.24.3. Product & Services
12.25. Medtronic plc
12.25.1. Business Overview
12.25.2. Key Executives
12.25.3. Product & Services
12.26. Nihon Kohden Corporation
12.26.1. Business Overview
12.26.2. Key Executives
12.26.3. Product & Services
12.27. Olympus Corporation
12.27.1. Business Overview
12.27.2. Key Executives
12.27.3. Product & Services
12.28. ResMed Inc.
12.28.1. Business Overview
12.28.2. Key Executives
12.28.3. Product & Services
12.29. Sartorius Stedim Biotech S.A.
12.29.1. Business Overview
12.29.2. Key Executives
12.29.3. Product & Services
12.30. Siemens Healthineers
12.30.1. Business Overview
12.30.2. Key Executives
12.30.3. Product & Services
12.31. Skanray Technologies Pvt. Ltd
12.31.1. Business Overview
12.31.2. Key Executives
12.31.3. Product & Services
12.32. Smith & Nephew PLC
12.32.1. Business Overview
12.32.2. Key Executives
12.32.3. Product & Services
12.33. Smiths Medical, Inc.
12.33.1. Business Overview
12.33.2. Key Executives
12.33.3. Product & Services
12.34. Steris PLC
12.34.1. Business Overview
12.34.2. Key Executives
12.34.3. Product & Services
12.35. Straumann Holding AG
12.35.1. Business Overview
12.35.2. Key Executives
12.35.3. Product & Services
12.36. Stryker Corporation
12.36.1. Business Overview
12.36.2. Key Executives
12.36.3. Product & Services
12.37. Teleflex Inc.
12.37.1. Business Overview
12.37.2. Key Executives
12.37.3. Product & Services
12.38. Terumo Corporation
12.38.1. Business Overview
12.38.2. Key Executives
12.38.3. Product & Services
12.39. The Cooper Companies Inc.
12.39.1. Business Overview
12.39.2. Key Executives
12.39.3. Product & Services
12.40. Zimmer Biomet Holdings
12.40.1. Business Overview
12.40.2. Key Executives
12.40.3. Product & Services

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing